Emphasizing the need for clinical guidelines for the treatment of multiple sclerosis (MS), Leslie Fish, PharmD, explains that national guidelines would be helpful when determining the appropriateness of first-line versus second-line therapy.
Dr Fish believes that national guidelines would provide helpful information about treatment effectiveness, and could define which agents should be recommended as second-line therapy based on their side effects.
Gary M. Owens, MD, recognizes that there is no single preferred agent for the treatment of MS and clinicians have fallen into a poor trend as they commonly recommend the most popular options as first-line treatment.
For this reason, there is hesitancy from insurers and clinicians about utilizing newer oral agents for treatment. Dr Owens believes that this issue needs to be addressed, especially as new agents continue to develop.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
What We’re Reading: ChatGPT in Health Care; Menthol Ban Meeting; Health System Cyberattack Impact
November 30th 2023ChatGPT is changing health care while also raising questions about artificial intelligence's promises and limitations; 24 Biden officials met with the National Organization of Black Law Enforcement Executives to discuss the FDA’s proposal to ban menthol cigarettes; a recent hospital cyberattack shows how the vulnerability of health care systems can put patients at risk.
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen